Initially metastatic bladder carcinoma in a 31-year-old patient.

Abstract

Bladder cancer is the fifth most common malignancy, peaks in incidence after the sixth decade of life. reports of the clinical behavior of bladder cancer specifically in young patients are restricted to small series. While some hereditary syndromes such as Li-Fraumeni or retinoblastoma carry an increased risk of urothelial tumors at an early age. their low prevalence means that few clinicians see such cases. This pathology occurs mainly in the male patient and with a prevalence of 4 % in the male patient younger than 40 years old. The same identified factors found in the elderly patient were identified in the youthful patients. Clinically, like in the older patients, hematuria, irritative symptoms (urgency, frequency, dysuria) and clinical decline were described before the confirmed diagnosis. Bladder tumors are usually superficial before the age of 40 therefore have a low aggressivity rate. Treatment of invasive bladder cancer in young patients does not differ from the treatment at an old age. Also, the prognosis of patients under 40 years of age with bladder carcinoma is claimed to be better than of those presenting in later life.